ArticleInternational journal of general medicine2025
Correlation Between Serum Creatinine-to-Cystatin C Ratio and Prognosis of Patients with Hip Fracture.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Secondary fracture risk after hip fracture in older patients: an updated sex-specific systematic review and meta analysis with GRADE and PAF assessment.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the association between the serum creatinine-to-cystatin C ratio (CCR) and the prognosis of patients with hip fracture. Methods: This retrospective cohort study included patients who underwent hip fracture surgery at a tertiary hospital in China between January 2018 and December 2023. CCR was calculated from the preoperative serum creatinine and cystatin C levels. The primary outcome was 1-year mortality after surgery in patients with hip fracture and the secondary outcome was 6-month mortality. The associations between preoperative CCR and prognosis of patients were assessed using Kaplan-Meier curves, Cox regression models, interactions, and stratified analyses. Results: A total of 1914 patients who underwent surgery for hip fracture were included. The mean age of the participants was 73.4 ± 14.0 years and the median CCR was 7.3 (6.3-8.5). The prevalence of 1-year mortality flowing hip fracture surgery was 7.3%. Multivariate Cox regression analysis indicated that a high CCR was independently associated with reduced 6-month mortality [hazard ratio (HR) = 0.51; 95% confidence interval (CI) = 0.31-0.84] and 1-year mortality (HR = 0.61; 95% CI = 0.42-0.90) after adjusting for covariates. In addition, Kaplan-Meier curve analyses indicated that the low CCR group had higher 6-month and 1-year mortality rates (all Conclusion: Our study found that a low CCR was associated with poor prognosis in patients undergoing hip fracture surgery. Further research is needed to clarify the mechanism linking low CCR to poor prognosis in hip fracture patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.